Search results
Author(s):
Uchenna Ozo
,
Sanjay Sharma
Added:
3 years ago
Athletes may occasionally succumb to sudden cardiac arrest because of a quiescent cardiac abnormality. These catastrophes are rare, affecting between 1 in 17,000 to 1 in 50,000 athletes, depending on the sporting discipline.1,2 Most deaths affect male athletes participating in explosive sports of a start–stop nature, such as basketball and soccer, and occur during or immediately after exercise.1…
View more
Author(s):
Aneil Malhotra
,
Sanjay Sharma
Added:
3 years ago
Athletes who perform regular and intensive exercise regimes develop a variety of electrical and structural cardiac adaptations that manifest functionally to improve stroke volume and performance. Up to one-fifth of young athletes (aged between 14–35 years) reveal greater left ventricular (LV) wall thickness compared to sedentary controls, though the majority fall under 12 mm.1,2 A small…
View more
Author(s):
Luokai Wang
,
Tee Joo Yeo
,
Benedict Tan
,
et al
Added:
2 years ago
Sudden Cardiac Death in Athletes
Author(s):
Andrew D’Silva
,
Michael Papadakis
Added:
3 years ago
Article
Author(s):
Paulus Kirchhof
Added:
3 years ago
Prof Paulus Kirchhof (University Heart and Vascular Center UKE Hamburg, Hamburg, DE) discusses results of the EAST – AFNET 4 Study.
The study prospectively tests the hypothesis that an early, structured rhythm control therapy based on antiarrhythmic drugs and catheter ablation can prevent atrial fibrillation (AF) related complications in patients with AF when compared to usual care.
Questions…
View more
Author(s):
Natalie Koh
,
Brian Ference
,
Stephen J Nicholls
,
et al
Added:
2 years ago
Author(s):
Paulus Kirchhof
Added:
2 years ago
In this video interview from EHRA 2022, Dr Paulus Kirchhof (University Heart Center Hamburg, Hamburg, DE) discusses the outcomes of the EAST-AFNET 4 Study, and the applicability of these findings in clinical practice.
Discussion points:
An outline of the EAST-AFNET 4 Study
Benefits of early AF treatment
Observations from clinical practice
Take-home messages
Further research required
…
View more
Author(s):
Shino Kany
Added:
1 year ago
AHA 22 - Dr Shino Kany (Broad Institute of MIT and Harvard, Cambridge, MA, US) joins us to discuss the association of genetic risk and outcomes in patients receiving early rhythm control therapy for atrial fibrillation in the EAST-AFNET 4 trial.
EAST-AFNET 4 aimed to compare early rhythm control to usual care amongst patients with a recent diagnosis of atrial fibrillation, randomised in a 1:1…
View more
Author(s):
Daniel TT Chong
,
Felicita Andreotti
,
Peter Verhamme
,
et al
Added:
2 years ago